Metrics of neonatal antibiotic use

Area of Science:

• Neonatal medicine
• Pharmacology
• Healthcare quality improvement

Background:

• Responsible antibiotic use is crucial for maintaining drug efficacy and preventing adverse events.
• Newborn infants experience high rates of antibiotic exposure, necessitating specific evaluation.
• Existing antibiotic use metrics require detailed assessment for their applicability in neonatal populations.

Purpose of the Study:

• To review and compare existing antibiotic use metrics for neonatal populations.
• To identify the advantages and limitations of current metrics in neonatal care.
• To explore future directions for developing accurate and meaningful metrics for neonatal antibiotic stewardship.

Main Methods:

• Systematic review and comparison of existing antibiotic use metrics.
• Analysis of metric definitions, applications, advantages, and limitations.
• Focus on the applicability of metrics to neonatal populations.

Main Results:

• Existing metrics vary in their definitions, applications, and suitability for neonatal populations.
• Current metrics have limitations in accurately reflecting and guiding neonatal antibiotic utilization.
• There is a need for refined or novel metrics tailored to the unique characteristics of neonates.

Conclusions:

• Improved metrics are essential for optimizing antibiotic use in newborns.
• Accurate metrics will enable targeted interventions to enhance neonatal safety and care quality.
• Future research should focus on developing and validating precise metrics for neonatal antibiotic stewardship.